Cure8

Why This Matters

This trial tested whether an 8-week tele-CBT program can reduce IBD-related disability measured by the validated IBD Disability Index. If effective, tele-CBT could expand access to psychosocial care and improve daily functioning for people with Crohn's disease or ulcerative colitis.

Who Should Pay Attention

Adult patients with Crohn's disease or ulcerative colitis who report moderate-to-severe disability; gastroenterologists and IBD care teams; mental health clinicians interested in GI populations; researchers of psychosocial interventions and telehealth.

Study Snapshot

Story typeClinical Reference
Trial phaseNA
Enrollment715 participants
Study statusCompleted
Source depthTrial registry record

What To Know

This ClinicalTrials.gov record reports a completed multi-site randomized trial testing telemedicine-delivered cognitive behavioral therapy (Tele-CBT) versus usual care for adults with IBD who have moderate-to-severe disability on the 14-item IBD Disability Index (IBD-DI). The intervention is eight weekly 1-hour teletherapy sessions with a licensed Ph.D.

psychologist plus usual care and access to an IBD Help Center; the primary outcome is change in IBD-DI from baseline to 8 weeks. The study screened adults with Crohn's disease or ulcerative colitis at five gastroenterology practices and enrolled participants with higher disability scores into the randomized phase.

Eligibility required English proficiency, ability to participate in telemedicine, and no recent relationship with a mental health specialist. The registry lists the University of Pennsylvania as the lead site and notes the trial is completed.

This record describes the trial design and primary outcome measure but does not present results or effect sizes in the provided text. For clinical decisions or expectations about benefit, look for a linked results posting or a peer-reviewed publication of trial outcomes.

Keep In Mind

The registry entry describes study design and primary outcome but does not include outcome data in the provided text. This is a trial-record summary; look for a results posting on ClinicalTrials.gov or a peer-reviewed publication for findings.

Source Details

Review the original publication for the complete reporting, methods, and context.

Read Original Source
Clinical trial Evidence type derived from source or registry metadata.
PublicationClinicalTrials.gov
SponsorUniversity of Pennsylvania
Trial IDNCT05635292
Study typeInterventional
Trial phaseNA
Enrollment715 participants
Indexed viaClinicalTrials.gov
Source typeTrial registry record
PublishedOct 23, 2026, 12:00 AM
Content availableTrial registry record

This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.

Related Reading

Browse latest news →